Thanks Mozz for your time replying to my message and appreciate you noting to question a higher authority on the tiredness. Be interesting to see if the bakers cyst resolves. Bassman it was great that you have came into the discussion and offered your experiences! It is always really nice to hear the stories from others who had tried our juice. And as you have indicated you had some really positive experiences which is fantastic for you. I also appreciate the variation in the doses which can vary between different chemists. This is something that certainly crossed my mind as I did not fully understand the exact dosage that was prescribed to my wife. I do recall that there were two different concentrations on offer. One was higher concentration and lower dosage while the other lower conc and higher volume. I am not 100% now on which they prescribed. Will need to check.
Rughound thanks for your input, I will tell my wife that your partner experienced lethargy which may have been from the med.
Douglasmorgon I am not an expert in this field. But my understanding is the drug formulated from the chemist is a similar form to what Bene has produced. There are thousands of different combinations of the carbon and sulphur chains so the exact formula of the bene compound could never be copied but I believe that each would be very similar in their overall formula and in their effects. I am not sure of the formula that is used on animals or the dosage. Mozz may be more educated in this area.
- Forums
- ASX - By Stock
- compounding chemist
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
0.00%
!
31.0¢

Thanks Mozz for your time replying to my message and appreciate...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $120.7M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 29.0¢ | $151.6K | 495.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 30530 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 2182 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 30530 | 0.290 |
4 | 81205 | 0.285 |
18 | 351187 | 0.280 |
6 | 64032 | 0.275 |
5 | 95941 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 2182 | 1 |
0.315 | 70433 | 5 |
0.320 | 108906 | 8 |
0.325 | 171282 | 7 |
0.335 | 25000 | 2 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online